Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis

RATIONALE: Pulmonary Alveolar Proteinosis (PAP) patients exhibit an acquired deficiency of biologically active granulocyte-macrophage colony stimulating factor (GM-CSF) attributable to GM-CSF specific autoantibodies. PAP alveolar macrophages are foamy, lipid-filled cells with impaired surfactant cle...

Descripción completa

Detalles Bibliográficos
Autores principales: Malur, Anagha, Kavuru, Mani S, Marshall, Irene, Barna, Barbara P, Huizar, Isham, Karnekar, Reema, Thomassen, Mary Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432632/
https://www.ncbi.nlm.nih.gov/pubmed/22697800
http://dx.doi.org/10.1186/1465-9921-13-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432632/
https://www.ncbi.nlm.nih.gov/pubmed/22697800
http://dx.doi.org/10.1186/1465-9921-13-46

Ejemplares similares